Patent ID: 11896667
Assignee: UCB PHARMA S.A.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method for treating osteoporosis in a mammalian subject, which method comprises:
(a) administering a batch of at least five doses of an anti-sclerostin antibody to a subject in need of such treatment, wherein the doses in the batch are administered at intervals of three to six weeks, and wherein the anti-sclerostin antibody comprises a CDR-H1 of SEQ ID NO:245, a CDR-H2 of SEQ ID NO:246, a CDR-H3 of SEQ ID NO:247, a CDR-L1 of SEQ ID NO:78, a CDR-L2 of SEQ ID NO:79 and a CDR-L3 of SEQ ID NO: 80;
(b) allowing the subject a dosing holiday that is at least twelve months in length; and
(c) administering to the subject a further batch of at least five doses of the anti-sclerostin antibody after the dosing holiday of (b).